Differentiation of malignant pleural mesothelioma from other pleural diseases

Thorax

Volumn 67, Issue 1, 2012, Pages 61-

  Bhardwaj, R ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 3; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADENOCARCINOMA; CANCER CELL; COL3A1 GENE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHUMAN; NOTE; ONCOGENE; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; TUMOR BIOPSY;

EID: 84855201516     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2011-200355     Document Type: Note

References (1)

1. Gueugnon F, Leclercq S, Blanquart C, et al. Identification of novel markers for the diagnosis of malignant pleural mesothelioma. Am J Pathol 2011;178:1033-42.